X-BATT Announces Joint Venture to Revolutionize Battery Technology with Coal
OVIEDO, Fla.–(BUSINESS WIRE)–X-BATT, a pioneer in advanced battery materials, is excited to announce that it…
News
Fujitsu and RIKEN develop AI drug discovery technology utilizing generative AI to predict structural changes in proteins
TOKYO, Oct 10, 2023 – (JCN Newswire) – Fujitsu Limited and the HPC- and AI-driven…
Global Losses to Scammers Exceed $1 Trillion as 1-in-4 Lose Money to Fraudsters
AMSTERDAM, Oct 10, 2023 – (ACN Newswire) – The latest annual study by the Global Anti-Scam…
DT50 Unveils 2023 Nominees: Honouring Tech Visionaries in a Year of Innovation
JAKARTA, Oct 10, 2023 – (ACN Newswire) – The DT50 is a prestigious award program…
Mendel Launches Hypercube, an AI-Copilot for Real World Data Applications
New offering arms life sciences with novel clinical AI to democratize analytics across the organization…
Seabury Aviation Group and Seabury Airline Strategy Group Enlist Rob Gurney as Strategic Advisor
Former oneworld Chief Executive Bolsters Companies’ Distribution, Technology & SAF-focused Capabilities NEW YORK–(BUSINESS WIRE)–#RobGurney–Seabury Aviation…
DUOS Launches AI-Informed Platform to Connect Older Adults with Vital Resources
At the HLTH Conference, DUOS is Unveiling a New Product Leveraging Artificial Intelligence to Match…
Edge Impulse Debuts Smallest, Most Precise HRV Algorithm, Alongside Other Health-Focused Tools
Innovators in the health space including Know Labs, Oura, Nowatch, Hyfe and SlateSafety use Edge…
Valo Therapeutics Announces Acquisition of Bruker Corporation’s Latest Mass Spectrometer Platform for Tumor Antigen Identification with ValoTx’s PeptiCHIP Technology
Top-of-the-Line Molecular Analytics Instrument with Transformative Sensitivity will enable Rapid Identification of Tumor Antigens HELSINKI,…
Valo Therapeutics Announces Acquisition of Bruker Corporation’s Latest Mass Spectrometer Platform for Tumor Antigen Identification with ValoTx’s PeptiCHIP Technology
Top-of-the-Line Molecular Analytics Instrument with Transformative Sensitivity will enable Rapid Identification of Tumor Antigens HELSINKI,…
GPCR Therapeutics Expands Pipeline into Fibrosis with a Combination Approach Targeting LPA1
SEOUL, Korea and REDWOOD CITY, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) — GPCR Therapeutics, Inc.,…
GPCR Therapeutics Expands Pipeline into Fibrosis with a Combination Approach Targeting LPA1
SEOUL, Korea and REDWOOD CITY, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) — GPCR Therapeutics, Inc.,…
Salipro Biotech and Icosagen Launch Antibody Discovery Collaboration
Salipro Biotech and Icosagen announce the initiation of a multi-target collaboration for the discovery and…
Salipro Biotech and Icosagen Launch Antibody Discovery Collaboration
Salipro Biotech and Icosagen announce the initiation of a multi-target collaboration for the discovery and…
Sosei Heptares and PharmEnable Therapeutics Expand Drug Discovery Collaboration
The collaboration combines Sosei Heptares’ leading structure-based drug design platform with PharmEnable’s advanced artificial intelligence-enabled…
Sosei Heptares and PharmEnable Therapeutics Expand Drug Discovery Collaboration
The collaboration combines Sosei Heptares’ leading structure-based drug design platform with PharmEnable’s advanced artificial intelligence-enabled…
Novozymes announce the Executive Leadership Team and organizational structure for the future combined company of Novozymes and Chr. Hansen
October 10, 2023 Please see attachment. Contact information Investor RelationsAnders Mohr Christensen+45 2515 2364dkamc@chr-hansen.com Press…
Novozymes announce the Executive Leadership Team and organizational structure for the future combined company of Novozymes and Chr. Hansen
October 10, 2023 Please see attachment. Contact information Investor RelationsAnders Mohr Christensen+45 2515 2364dkamc@chr-hansen.com Press…
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings
VANCOUVER, British Columbia, Oct. 10, 2023 (GLOBE NEWSWIRE) — Mydecine Innovations Group, Inc. (“Mydecine” or…
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings
VANCOUVER, British Columbia, Oct. 10, 2023 (GLOBE NEWSWIRE) — Mydecine Innovations Group, Inc. (“Mydecine” or…